Loading
Hanchor-KY: what insiders have been doing
This page follows insider dealings at Hanchor-KY as filed with TWSE / TPEx (MOPS). Between 18 October 2025 and 18 October 2026, 2 insiders published 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Insider buying of Hanchor-KY has been absent for the past year.
Across the 515 companies tracked on its exchange, the median is 2 filings; at 2 filings, this issuer sits right on that mark.
This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 18,930 of 24,161 companies
32.1
score / 100
Value30
Quality34
FCF yld-1.3%
Earn yld-1.0%
EV/EBITDA·
ROE-86%
Gross mgn100%
Net mgn-89%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NT$164
Analyst consensus
Income statement
RevenueNT$312.2M
Gross profitNT$312.2M100% margin
EBITDA-NT$328.1M-105% margin
Net income-NT$276.7M-177.9% margin
Valuation
PER (trailing)21.4x
P/Book17.3x
Beta-0.37
Balance sheet & cash
Market capNT$26.5B
Total debtNT$101.4M
Free Cash Flow-NT$337.2M
Debt / Equity10%
Profitability & ownership
ROE-85.6%
ROA-36.2%
% insiders0.0%
% institutions0.4%
Last declaration on 5 October 2026
About Hanchor-KY
漢康-KY創 is a company listed on the XTAI market, specializing in the healthcare sector.